Literature DB >> 18214786

Congenital fibrosis of the extraocular muscles.

Gena Heidary1, Elizabeth C Engle, David G Hunter.   

Abstract

Congenital fibrosis of the extraocular muscles (CFEOM) is a strabismus syndrome characterized by non-progressive, restrictive ophthalmoplegia of the extraocular muscles and congenital blepharoptosis. Three clinical phenotypes for familial CFEOM (CFEOM1, 2, and 3) have been delineated, for which two genes have been identified to date: KIF21A for CFEOM1 and 3 and PHOX2A/ARIX for CFEOM2. Insights gained from molecular genetics have strengthened the hypothesis that CFEOM results from the dysinnervation of the extraocular muscles supplied by the oculomotor and/or trochlear nerves. Continued study of this syndrome should help to further elucidate the pathogenesis of eye movement disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18214786     DOI: 10.1080/08820530701745181

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  20 in total

1.  Dissociated vertical deviation in congenital fibrosis of the extraocular muscles.

Authors:  Se Rang Choi; Seung-Hee Baek; Ungsoo Samuel Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-15       Impact factor: 3.117

2.  Cerebellar atrophy in congenital fibrosis of the extraocular muscles type 1.

Authors:  Roberto Di Fabio; Giovanna Comanducci; Francesca Piccolo; Filippo Maria Santorelli; Teresa De Berardinis; Alessandra Tessa; Umberto Sabatini; Francesco Pierelli; Carlo Casali
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

3.  Kinesin-4 KIF21B is a potent microtubule pausing factor.

Authors:  Wilhelmina E van Riel; Ankit Rai; Sarah Bianchi; Eugene A Katrukha; Qingyang Liu; Albert Jr Heck; Casper C Hoogenraad; Michel O Steinmetz; Lukas C Kapitein; Anna Akhmanova
Journal:  Elife       Date:  2017-03-14       Impact factor: 8.140

4.  KIF21A-mediated axonal transport and selective endocytosis underlie the polarized targeting of NCKX2.

Authors:  Kyu-Hee Lee; Jae Sung Lee; Doyun Lee; Dae-Hyun Seog; Jonathan Lytton; Won-Kyung Ho; Suk-Ho Lee
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

5.  Associated morbidity of pediatric ptosis - a large, community based case-control study.

Authors:  Arie Y Nemet; Ori Segal; Michael Mimouni; Shlomo Vinker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-13       Impact factor: 3.117

6.  Efa6 protects axons and regulates their growth and branching by inhibiting microtubule polymerisation at the cortex.

Authors:  Yue Qu; Ines Hahn; Meredith Lees; Jill Parkin; André Voelzmann; Karel Dorey; Alex Rathbone; Claire T Friel; Victoria J Allan; Pilar Okenve-Ramos; Natalia Sanchez-Soriano; Andreas Prokop
Journal:  Elife       Date:  2019-11-13       Impact factor: 8.140

7.  Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges.

Authors:  Michael T Lovci; Dana Ghanem; Henry Marr; Justin Arnold; Sherry Gee; Marilyn Parra; Tiffany Y Liang; Thomas J Stark; Lauren T Gehman; Shawn Hoon; Katlin B Massirer; Gabriel A Pratt; Douglas L Black; Joe W Gray; John G Conboy; Gene W Yeo
Journal:  Nat Struct Mol Biol       Date:  2013-11-10       Impact factor: 15.369

8.  KIF21A mRNA expression in patients with Down syndrome.

Authors:  Michele Salemi; Concetta Barone; Carmelo Romano; Federico Ridolfo; Cataldo Scavuzzo; Rita Anna Cantarella; Maria Grazia Salluzzo; Aldo E Calogero; Corrado Romano; Paolo Bosco
Journal:  Neurol Sci       Date:  2012-09-12       Impact factor: 3.307

9.  Structural analyses of key features in the KANK1·KIF21A complex yield mechanistic insights into the cross-talk between microtubules and the cell cortex.

Authors:  Zhuangfeng Weng; Yuan Shang; Deqiang Yao; Jinwei Zhu; Rongguang Zhang
Journal:  J Biol Chem       Date:  2017-11-20       Impact factor: 5.157

10.  Two unique TUBB3 mutations cause both CFEOM3 and malformations of cortical development.

Authors:  Mary C Whitman; Caroline Andrews; Wai-Man Chan; Max A Tischfield; Steven F Stasheff; Francesco Brancati; Xilma Ortiz-Gonzalez; Sara Nuovo; Francesco Garaci; Sarah E MacKinnon; David G Hunter; P Ellen Grant; Elizabeth C Engle
Journal:  Am J Med Genet A       Date:  2015-12-06       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.